These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9027616

  • 1. Clinical detection of lung cancer progression markers.
    Tockman MS.
    J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
    [Abstract] [Full Text] [Related]

  • 2. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
    Qiao YL, Tockman MS, Li L, Erozan YS, Yao SX, Barrett MJ, Zhou WH, Giffen CA, Luo XC, Taylor PR.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
    [Abstract] [Full Text] [Related]

  • 3. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
    Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, Taylor PR, Zhukov T, Zhou WH, Qiao YL, Yao SX.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
    Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H.
    Cancer Res; 1999 Apr 01; 59(7):1404-7. PubMed ID: 10197602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
    Peebles KA, Dwyer-Nield LD, Malkinson AM.
    Mol Carcinog; 2007 Nov 01; 46(11):887-900. PubMed ID: 17477362
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].
    Wang L, Wang G, Xia X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr 01; 21(4):236-9. PubMed ID: 11326973
    [Abstract] [Full Text] [Related]

  • 10. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
    Sueoka E, Sueoka N, Iwanaga K, Sato A, Suga K, Hayashi S, Nagasawa K, Nakachi K.
    Lung Cancer; 2005 Apr 01; 48(1):77-83. PubMed ID: 15777973
    [Abstract] [Full Text] [Related]

  • 11. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS, Franklin WA, Drabkin H, Gemmill R, Sidransky D, Anderson MW.
    J Cell Biochem Suppl; 1997 Apr 01; 28-29():64-73. PubMed ID: 9589350
    [Abstract] [Full Text] [Related]

  • 12. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.
    Zhou J, Mulshine JL, Ro JY, Avis I, Yu R, Lee JJ, Morice R, Lippman SM, Lee JS.
    Clin Cancer Res; 1998 Jul 01; 4(7):1631-40. PubMed ID: 9676837
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
    Katsimpoula S, Patrinou-Georgoula M, Makrilia N, Dimakou K, Guialis A, Orfanidou D, Syrigos KN.
    Anticancer Res; 2009 Apr 01; 29(4):1373-82. PubMed ID: 19414390
    [Abstract] [Full Text] [Related]

  • 14. Biological markers in lung cancer: A clinician's perspective.
    Tufman A, Huber RM.
    Cancer Biomark; 2010 Apr 01; 6(3-4):123-35. PubMed ID: 20660959
    [Abstract] [Full Text] [Related]

  • 15. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma.
    Anderson M, Sladon S, Michels R, Davidson L, Conwell K, Lechner J, Franklin W, Saccomanno G, Wiest J.
    J Cell Biochem Suppl; 1996 Apr 01; 25():185-90. PubMed ID: 9027617
    [Abstract] [Full Text] [Related]

  • 16. hnRNP B1 expression in benign and malignant lung disease.
    Snead DR, Perunovic B, Cullen N, Needham M, Dhillon DP, Satoh H, Kamma H.
    J Pathol; 2003 May 01; 200(1):88-94. PubMed ID: 12692846
    [Abstract] [Full Text] [Related]

  • 17. [Lung cancer].
    Haugen A.
    Tidsskr Nor Laegeforen; 1998 Jun 10; 118(15):2362-5. PubMed ID: 9691805
    [Abstract] [Full Text] [Related]

  • 18. Molecular diagnostic markers for lung cancer in sputum and plasma.
    Wang YC, Hsu HS, Chen TP, Chen JT.
    Ann N Y Acad Sci; 2006 Sep 10; 1075():179-84. PubMed ID: 17108209
    [Abstract] [Full Text] [Related]

  • 19. p53 and lung cancer.
    Brambilla E, Brambilla C.
    Pathol Biol (Paris); 1997 Dec 10; 45(10):852-63. PubMed ID: 9769949
    [Abstract] [Full Text] [Related]

  • 20. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.
    Cancer Res; 2002 Apr 15; 62(8):2370-7. PubMed ID: 11956099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.